Enhanced First Generation Adenovirus Vaccines Expressing Codon Optimized HIV1-Gag, Pol, Nef and Modifications

Details for Australian Patent Application No. 2001294562 (hide)

International Classifications

Event Publications

8 July 2004 Amendment Made

The nature of the amendment is: Add priority details 60/317,814 07 Sep 2001 US and 60/279,056 27 Mar 2001 US 2002

24 May 2007 Application Accepted

Published as AU-B-2001294562

5 July 2007 Corrigenda

Applications Accepted - Name Index Under the name Merck & Co., Inc., Corrigenda Application No. 2001294562, under INID (72), correct the co-inventor name to read Casimiro, Daniel R.

23 August 2007 Corrigenda

Applications Accepted - Name Index Under the name Merck & Co., Inc., Application No. 2001294562, under INID (72), correct the co-inventor name to read Casimiro, Danilo R.

20 September 2007 Standard Patent Sealed

8 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.